Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of medical microbiology · 2006
A prospective study was carried out to elucidate the clinical, epidemiological and laboratory features of human brucellosis. A total of 26 948 blood samples (from adults aged 15 years and above) were screened for serological evidence of brucellosis over a period of 16 years. The slide agglutination/Rose Bengal plate agglutination test gave positive results in 517 patients, of which 509 had detectable titres by the standard tube agglutination test (SAT). The diagnosis of brucellosis was documented in 495 (1.8 %) patients based on diagnostic titres (⩾1 : 160, 490 cases) and rising titres from insignificant titres (four cases) by serology and for one case by blood-culture isolation alone. Blood cultures were carried out in 345 cases, of which 191 cases (55.3 %) yieldedBrucella melitensis. In 77/79 cases undertaken for follow up, there was a steady fall in 2-mercaptoethanol (2ME) agglutination titres along with clinical improvement (P<0.01). SAT titres remained detectable in most cases for a longer period in spite of an effective antimicrobial therapy and clinical recovery. A substantial number of patients (84.2 %) presented with fever, this being the only complaint in 51.1 % of the cases. Complications were present in 8.8 % of the patients (arthritis excluded): this included the unusual complications of hydrocele (two cases), Stevens–Johnson syndrome (one case) and urinary tract infection (one case).Brucellaagglutinins were demonstrated in synovial, testicular, hydrocele and cerebrospinal fluids. There was no clinical suspicion of brucellosis in 439 cases (88.7 %) and the diagnosis was made only by routine serology. A two-drug regimen for 42–84 days with a follow-up 2ME test resulted in lower levels of relapse. These results suggest that, in endemic areas of the world, it should be mandatory to screen routinely for brucellosis due to protean clinical manifestations.
Pharmacogenetics and genomics · 2009
Journal of clinical and diagnostic research : JCDR · 2013
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Cureus · 2026 · Journal Article
Radhakrishnan C, Kunhumon SP, K TN, V U, et al.
Bioinformation · 2025 · Journal Article
G N, M SSL, V S, K S, et al.
Irish journal of medical science · 2025 · Journal Article
Parthasarathy B, K K, Selvam SP
Cureus · 2025 · Journal Article
Suyambulingam A, K A, Venkatesan A, Jayakaran V, et al.
Cureus · 2025 · Journal Article
Umer MR, Asghar A, Zar Nawaz MA, Maryam F, et al.
Journal of biomolecular structure & dynamics · 2025 · Journal Article
H S S, V G, T M N, Setlur AS, et al.
Bioinformation · 2025 · Journal Article
Ari G, Mohit J, Vilas K, K T, et al.
International journal of dermatology · 2024 · Case Reports
K S, Thakur V, Sethy M, Sahu DK, et al.
Cureus · 2023 · Case Reports
K M B, Gulla V, K R, Koneru S, et al.
Travel medicine and infectious disease · 2023 · Observational Study
Jeyaraman N, Jeyaraman M, Nallakumarasamy A, K S, et al.
Saudi journal of biological sciences · 2021 · Journal Article
Alanazi AF, Alenezy A, Alotiby A, Bukhari T, et al.
The spine journal : official journal of the North American Spine Society · 2021 · Journal Article
Rajasekaran S, Soundararajan DCR, Tangavel C, Nayagam SM, et al.
PloS one · 2020 · Journal Article
Desai G, T S J, G SK, L M, et al.
Current pharmaceutical design · 2016 · Journal Article
Prabhakaran K, Ramasamy G, Doraisamy U, Mannu J, et al.
Journal of clinical and diagnostic research : JCDR · 2014 · Case Reports
Kumar S P, K P
Journal of clinical and diagnostic research : JCDR · 2013 · Journal Article
Vs K, K P, Ramesh M, Venkatesan V
Journal of medical microbiology · 2006 · Journal Article
Mantur BG, Biradar MS, Bidri RC, Mulimani MS, et al.
Cureus · 2026 · Journal Article
Kerketta AH, Rathod AP, Nagori J, Bhagat PR, et al.
Cureus · 2026 · Journal Article
R GS, K N
Cureus · 2025 · Case Reports
K A, Kumar S, M V B, Ramadurai S, et al.
MethodsX · 2025 · Journal Article
Srivastava S, Nair A, U DKK, Kovela RK, et al.
Cureus · 2025 · Case Reports
K R, J P, R R, B V MM, et al.
Cureus · 2024 · Case Reports
Pandian U, K A, Rajesh Lenin R, Dev A, et al.
MethodsX · 2025 · Journal Article
Srivastava S, Nair A, U DKK, Kovela RK, et al.
Journal of neurosciences in rural practice · 2021 · Journal Article
Unni C, Pettakkandy V, P AJ, Soren SK, et al.
Pharmacogenetics and genomics · 2009 · Journal Article
Sharma S, Das M, Kumar A, Marwaha V, et al.
Journal of thoracic disease · 2012 · Journal Article
Mohammad Y, Shaaban R, Yassine F, Allouch J, et al.
Cureus · 2025 · Journal Article
Suyambulingam A, K A, Jayakaran V, Venkatesan A, et al.
Ocular immunology and inflammation · 2024 · Journal Article
Dutta Majumder P, Agarwal S, Shah M, Srinivasan B, et al.
Journal of neurosciences in rural practice · 2021 · Journal Article
Unni C, Pettakkandy V, P AJ, Soren SK, et al.